GoodRx Holdings, Inc. (GDRX) Return on equity 2020–2025
GoodRx Holdings, Inc. (GDRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
4.9%FY2025 · since FY2020: -41.3% → 4.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 4.9% | +2.7 pp |
| FY2024 | 2.3% | +3.4 pp |
| FY2023 | -1.2% | +2.9 pp |
| FY2022 | -4.0% | -1.0 pp |
| FY2021 | -3.0% | +38.2 pp |
| FY2020 | -41.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More GDRX financial trends
GDRX RevenueGDRX Net incomeGDRX Net marginGDRX Gross profitGDRX Gross marginGDRX Operating incomeGDRX Operating marginGDRX Operating cash flowGDRX Free cash flowGDRX Capital expendituresGDRX Stock buybacksGDRX Dividends paidGDRX Total assetsGDRX Total liabilitiesGDRX Shareholders’ equityGDRX overview →